Sudeep Pharma Ltd
NSE: SUDEEPPHRM | BSE: 544619
₹848.50
₹27.40
(3.34%)
As on 30-Jun-2026IST
Market cap
₹9,572 Cr
Revenue (TTM)
₹502 Cr
P/E Ratio
55.4
P/B Ratio
10.8
Div. Yield
0.2 %
Quality Score
10/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹139 Cr
-
ROE
32.8 %
-
ROCE
35.8 %
-
Industry P/E
52.16
-
EV/EBITDA
38.3
-
Debt to Equity
0.3
-
Book Value
₹50.5
-
EPS
₹14.3
-
Face value
1
-
Shares outstanding
112,948,625
10 Years Aggregate
CFO
₹98.87 Cr
EBITDA
₹650.12 Cr
Net Profit
₹469.12 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
| 40.8 | 14.3 | 39.8 | -- | -- | -- | -- |
|
BSE Healthcare
| 13.5 | 5.3 | 18.0 | 12.0 | 24.4 | 14.1 | 12.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
|
848.5 | 9,572.4 | 502.0 | 138.7 | -- | 32.8 | 55.4 | 10.8 |
| 1,156.5 | 14,189.3 | 2,551.8 | 564.5 | 28.3 | 18.4 | 25.1 | 4.3 | |
| 525.2 | 9,098.3 | 947.3 | 247.8 | 28.5 | 18.9 | 36.7 | 6.7 | |
| 1,280.2 | 13,368.4 | 1,054.9 | 256.3 | 27.8 | 13.7 | 51.2 | 6.6 | |
| 1,836.0 | 34,823.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 37.7 | 7.0 | |
| 397.5 | 4,323.7 | 165.8 | 46.7 | 37.8 | 16.9 | 92.6 | 15.0 | |
| 18,579.0 | 23,902.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 65.7 | 12.8 | |
| 972.8 | 4,945.4 | 811.3 | 21.0 | 0.7 | 2.1 | 240.7 | 3.8 | |
| 1,329.9 | 6,124.9 | 649.5 | 121.6 | 23.7 | 13.2 | 53.1 | 6.6 | |
| 280.7 | 7,412.9 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 12.5 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Sudeep Pharma
--
-
Incorporated
1989
-
Chairman
Sujit Jaysukh Bhayani
-
Managing Director
Sujit Jaysukh Bhayani
-
Headquarters
Vadodara, Gujarat
-
Website
Looking for more details about Sudeep Pharma Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
FAQs for Sudeep Pharma
What is the current share price of Sudeep Pharma Ltd Today?
The share price of Sudeep Pharma Ltd is ₹848.50 (NSE) and ₹847.50 (BSE) as of 30-Jun-2026 IST. Sudeep Pharma Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Sudeep Pharma Ltd?
The P/E ratio of Sudeep Pharma Ltd is 55.37 times as on 30-Jun-2026, a 6 premium to its peers’ median range of 52.16 times.
The P/B ratio of Sudeep Pharma Ltd is 10.84 times as on 30-Jun-2026, a 100 premium to its peers’ median range of 5.41 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Sudeep Pharma Ltd?
The 52-week high and low of Sudeep Pharma Ltd are Rs 882.40 and Rs 524.05 as of 01-Jul-2026.
What is the market cap of Sudeep Pharma Ltd?
Sudeep Pharma Ltd has a market capitalisation of ₹ 9,572 Cr as on 30-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sudeep Pharma Ltd?
Before investing in Sudeep Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.